Clinical Trial Update: Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is planned to evaluate sacubitril/valsartan in patients with essential hypertension and type 2 diabetic nephropathy; the study is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Essential Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: Sichuan Academy of Medical Sciences | Conditions: Essential Hypertension, Type 2 Diabetes | Phase 4 | Status: NOT_YET_RECRUITING